Peter Lynch fit · Growth at a reasonable price (GARP)
Is Amphastar Pharmaceuticals, Inc. (AMPH) a Peter Lynch Stock?
Strong GARP candidate — growth at a reasonable price.
75/100
BProbable acción Lynch
5/6 criterios cumplidos
Los criterios de Peter Lynch, aplicados a AMPH
PEG ≤ 1.0
clave—
EPS CAGR ≥ 15%
clave181.1%
Revenue CAGR ≥ 10%
17.4%
Net margin > 0
15.4%
Cómo se valora AMPH en otras estrategias
Datos financieros en vivo
Cap. mercado
$1.19B
PER (TTM)
7.9x
ROIC (TTM)
12.28%
Margen bruto
49.36%
Preguntas frecuentes
What is AMPH's Peter Lynch fit score?
AMPH scores 75/100 on our Peter Lynch fit engine — grade B. Strong GARP candidate — growth at a reasonable price.
Does Peter Lynch actually own AMPH?
Our score is computed from financial fundamentals against Peter Lynch's published criteria. We don't claim that Peter Lynch personally owns or recommends AMPH.
How often is this score updated?
AMPH's Peter Lynch fit score is recomputed daily from the latest TTM financials.
Herramienta educativa, no es asesoramiento financiero. Las puntuaciones se calculan a partir de datos financieros públicos contra los criterios publicados de cada estrategia de inversión. No afirmamos que Peter Lynch posea o recomiende AMPH personalmente.